Trials / Unknown
UnknownNCT05063214
Muscle Evaluation of Patients Infected by the Coronavirus
Muscle Evaluation of Patients Infected by the Coronavirus Requiring Mechanical Ventilation
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 138 (estimated)
- Sponsor
- Hospital Israelita Albert Einstein · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) presents risk to develop muscle weakness associated with prolonged period of mechanical ventilation support and hospital stay.
Detailed description
Intensive care unit (ICU) acquired muscle weakness affects both respiratory and peripheral muscles and can contribute to worsen clinical and functional outcomes. In this way, ultrasonography muscle evaluation could help to identify early alterations guiding the therapeutic planning and allowing to monitor the interventions performed. Therefore, the investigators intend to follow up mechanically ventilated patients with confirmed diagnosis of COVID-19 during ICU stay to quantify the diaphragm, parasternal intercostal, abdominals and femoral quadriceps muscles thickness assessed by ultrasonography. Additionally, functional capacity, frailty and level of physical activity will be evaluated and followed for pre-admission condition and 30, 90 and 180 days after hospital discharge .
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Muscle ultrasound evaluation | Muscle ultrasound evaluation will be performed in patients admitted with COVID-19 requiring invasive mechanical ventilation. The measurements of thickness and thickening fraction will occur for diaphragm, abdominal - rectus abdominis, internal oblique, external oblique and transverse abdomen - and parasternal intercostal muscles. Serial measurements of the thickness and echogenicity of the quadriceps femoris muscle will also be performed. |
Timeline
- Start date
- 2021-09-30
- Primary completion
- 2022-09-01
- Completion
- 2022-09-01
- First posted
- 2021-10-01
- Last updated
- 2021-10-06
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT05063214. Inclusion in this directory is not an endorsement.